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Abstract
AIM: To evaluate whether virtual chromoendoscopy 
can improve the delineation of small bowel lesions 
previously detected by conventional white light small 
bowel capsule endoscopy (SBCE). 
METHODS: Retrospective single center study. One 
hundred lesions selected from forty-nine consecutive 
conventional white light SBCE (SBCE-WL) examinations 
were included. Lesions were reviewed at three Flexible 
Spectral Imaging Color Enhancement (FICE) settings 
and Blue Filter (BF) by two gastroenterologists with ex-
perience in SBCE, blinded to each other’s findings, who 
ranked the quality of delineation as better, equivalent 
or worse than conventional SBCE-WL. Inter-observer 
percentage of agreement was determined and analyzed 
with Fleiss Kappa (k) coefficient. Lesions selected for 
the study included angioectasias (n  = 39), ulcers/ero-
sions (n  = 49) and villous edema/atrophy (n  = 12). 
RESULTS: Overall, the delineation of lesions was im-
proved in 77% of cases with FICE 1, 74% with FICE 2, 
41% with FICE 3 and 39% with the BF, with a percent-
age of agreement between investigators of 89% (k = 
0.833), 85% (k = 0.764), 66% (k = 0.486) and 79% (k 
= 0.593), respectively. FICE 1 improved the delineation 
of 97.4% of angioectasias, 63.3% of ulcers/erosions and 
66.7% of villous edema/atrophy with a percentage of 
agreement of 97.4% (k = 0.910), 81.6% (k = 0.714) 
and 91.7% (k = 0.815), respectively. FICE 2 improved 
the delineation of 97.4% of angioectasias, 57.1% of 
ulcers/erosions and 66.7% of villous edema/atrophy, 
with a percentage of agreement of 89.7% (k = 0.802), 
79,6% (k = 0.703) and 91.7% (k = 0.815), respectively. 
FICE 3 improved the delineation of 46.2% of angioecta-
sias, 24.5% of ulcers/erosions and none of the cases of 
villous edema/atrophy, with a percentage of agreement 
of 53.8% [k = not available (NA)], 75.5% (k = NA) and 
66.7% (k = 0.304), respectively. The BF improved the 
delineation of 15.4% of angioectasias, 61.2% of ulcers/
erosions and 25% of villous edema/atrophy, with a per-
centage of agreement of 76.9% (k = 0.558), 81.6% (k 
= 0.570) and 25.0% (k = NA), respectively.
CONCLUSION: Virtual chromoendoscopy can improve 
the delineation of angioectasias, ulcers/erosions and 
villous edema/atrophy detected by SBCE, with almost 
perfect interobserver agreement for FICE 1.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: One of the recent technical advances of small 
bowel capsule endoscopy (SBCE) technology is the pos-
sibility to enhance endoscopic imaging with computed 
virtual chromoendoscopy, using the Flexible Spectral 
Imaging Color Enhancement (FICE) or the Blue Filter 
modes. In our study, virtual chromoendoscopy, par-
ticularly FICE 1, improved the delineation of three main 
types of small bowel mucosal lesions: vascular (angio-
ectasias), mucosal breaks (ulcers and erosions) and 
villous pattern (edema and atrophy), with substantial 
inter-observer agreement. Thus, we support the use of 
virtual chromoendoscopy as a complement to conven-
tional white light SBCE for the evaluation of difficult to 
interpret endoscopic images.
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INTRODUCTION
Small bowel capsule endoscopy (SBCE) is a well estab-
lished diagnostic procedure for the evaluation of  small 
bowel diseases, with a high diagnostic yield when com-
pared to other small bowel imaging modalities[1-5]. Recently, 
SBCE diagnostic abilities have been further expanded with 
the incorporation of  virtual chromoendoscopy into the 
versions 6, 7 and 8 of  RAPID® Reader (Given® Imaging 
Ltd, Yoqneam, Israel)[6-8], using the Flexible Spectral Im-
aging Color Enhancement (FICE, Fujinon Corporation
®, Saitama, Japan) and the Blue Filter (BF). FICE uses a 
spectral estimation technology, narrowing the bandwidth 
of  white light that permits an automatic reconstruction 
of  pre-acquired conventional endoscopic images into 
virtual images with different wavelengths of  red, green 
and blue, in order to enhance vascular contrast and the 
resolution of  surface patterns[9,10]. The BF is another set-
ting of  virtual chromoendoscopy consisting of  colour 
enhancement within a short wavelength range (490-430 
nm). Virtual chromoendoscopy works with the conve-
nience of  a quick push-button switch between white 
light and chromoendoscopy with no need for dye spray-
ing[11]. Virtual chromoendoscopy has been extensively 
investigated in the upper and lower GI tract[9,12-14], and 
recently in double-balloon enteroscopy[15]. Despite the 
conflicting data, most studies support its use to improve 
the evaluation of  size, borders and mucosal pattern of  
different types of  lesions[9,11,16-18]. However, it is currently 
controversial whether virtual chromoendoscopy may 
increase the diagnostic yield and diagnostic accuracy of  
SBCE, and what are the optimal wavelength filters to be 
used[7,11,19]. 
The aim of  this study was to evaluate whether the 
currently available virtual chromoendoscopy settings may 
improve the delineation of  the most frequent small bowel 
mucosal lesions detected by conventional white light 
SBCE (SBCE-WL).
MATERIALS AND METHODS
Type of study and selection of participants
We conducted a retrospective single center study, which 
included forty nine consecutive SBCE examinations for 
the investigation of  patients with iron deficiency anemia, 
overt or occult obscure digestive bleeding and suspected 
or known Crohn’s disease. 
Procedures
All patients followed a 24 h clear liquid diet and 12 h fast-
ing prior to SBCE (PillCam® SB, Given® Imaging Ltd 
Yoqneam, Israel). No oral purge was administered. All 
videos were reviewed with conventional white light by a 
gastroenterologist with extensive experience on SBCE (> 
500 procedures), who selected 100 consecutive lesions to 
enter the study, including vascular lesions (angioectasias, 
n = 39), mucosal breaks (ulcers/erosions, n = 49) and vil-
lous morphology changes (villous edema/atrophy, n = 12) 
(Figure 1). All lesions were described using the terminol-
ogy proposed by the Given Capsule Endoscopy working 
group[20]. According to the methodology of  the study, two 
gastroenterologists with experience in SBCE (more than 
200 examinations) reviewed the selected lesions using all 
three FICE settings and the BF, and were blinded to each 
other’s evaluation. The settings used in the study were: 
FICE 1 (wavelength red 595 nm, green 540 nm, blue 535 
nm), FICE 2 (wavelength red 420 nm, green 520 nm, blue 
530 nm), FICE 3 (wavelength red 595 nm, green 570 nm, 
blue 415 nm) and BF (wavelength 490-430 nm). The se-
quence used by the reviewers was uniform, starting with 
FICE 1, then FICE 2, FICE 3 and finally the BF. 
Variables and outcomes
SBCE-WL and virtual chromoendoscopy images were 
compared regarding the contrast of  mucosal surface and 
clear demarcation of  the borders of  the lesions. Each 
investigator rated the delineation of  lesions with each 
setting of  FICE and BF mode as follows: +2 (remark-
ably better delineation with enhanced delineation of  le-
sion surface and/or borders), +1 (slight improvement), 
0 (equivalent to conventional SBCE-WL), -1 (worse 
delineation or inability to characterize a specific lesion). 
Finally, the scores attributed by the investigators were 
added for each lesion, such that a final score ≥ 2 was 
classified as better delineation, a score between 0 and 1 
was considered equivalent to conventional SBCE-WL, 
and a score ≤ -1 indicated worse delineation with virtual 
chromoendoscopy. 
Statistical analysis
Inter-observer percentage of  agreement was determined 
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and analyzed using Fleiss Kappa coefficient, such that k (k) 
< 0 indicated poor agreement, 0.00-0.20 slight agreement, 
0.21-0.40 fair agreement, 0.41-0.60 moderate agreement, 
0.61-0.80 substantial agreement, and 0.81-1.00 almost 
perfect agreement[21].
RESULTS
Overall, the delineation of  small bowel mucosal lesions 
was improved in 77% of  cases with FICE 1, 74% with 
FICE 2, 41% with FICE 3 and 39% with the BF, with a 
percentage of  agreement between the two investigators 
of  89% [k = 0.833 (P < 0.001), 95%CI: 0.741-0.925], 
85% [k = 0.764 (P < 0.001), 95%CI: 0.654-0.874], 66% 
[k = 0.486 (P < 0.001), 95%CI: 0.345-0.627] and 79% [k 
= 0.593 (P < 0.001), 95%CI: 0.438-0.748], respectively 
(Table 1). FICE 1 improved the delineation of  97.4% of  
vascular lesions (angioectasias), 63.3% of  mucosal breaks 
(ulcers/erosions) and 66.7% of  villous morphology 
changes (edema/atrophy), with a percentage of  agreement 
of  97.4% [k = 0.910 (P < 0.001), 95%CI: 0.736-1.084], 
81.6% [k = 0.714 (P < 0.001), 95%CI: 0.543-0.885 and 
91.7% [k = 0.815 (P < 0.001), 95%CI: 0.470-1.160], re-
spectively. FICE 2 improved the delineation of  97.4% of  
angioectasias, 57.1% of  ulcers/erosions and 66.7% of  
villous edema/atrophy, with a percentage of  agreement 
of  89.7% [k = 0.802 (P < 0.001), 95%CI: 0.620-0.984], 
79.6% [k = 0.703 (P < 0.001), 95%CI: 0.540-0.866] and 
91.7% [k = 0.815 (P < 0.001), 95%CI: 0.470-1.160], re-
spectively. FICE 3 improved the delineation of  46.2% 
of  angioectasias, 24.5% of  ulcers/erosions and none of  
the cases of  villous edema/atrophy, with a percentage 
of  agreement of  53.8% (k = NA), 75.5% (k = NA) and 
66.7% [k = 0.304 (P = 0.098), 95%CI: -0.091-0.700], 
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Figure 1  Small bowel mucosal lesions under conventional white light and virtual chromoendoscopy. A: Angioectasia; B: Ulcer; C: Villous edema. 
Table 1  Summary of results
Angioectasias (n  = 39) Ulcers/erosions (n  = 49) Villous edema/atrophy (n  = 12) Overall (n  = 100)
FICE 1
   Improved delineation 38/39 (97.4%) 31/49 (63.3%) 8/12 (66.7%) 77/100 (77.0%)
   Percentage of agreement, k 97.4%, k = 0.910 81.6%, k = 0.714 91.7%, k = 0.815 89.0%, k = 0.833
FICE 2
   Improved delineation 38/39 (97.4%) 28/49 (57.1%) 8/12 (66.7%) 74/100 (74.0%)
   Percentage of agreement, k 89.7%, k = 0.802 79.6%, k = 0.703 91.7%, k = 0.815 85.0%, k = 0.764
FICE 3
   Improved delineation 18/39 (46.2%) 12/49 (24.5%) 0/12 (0.0%) 41/100 (41.0%)
   Percentage of agreement, k 53.8%, k = NA 75.5%, k = NA 66.7%, k = 0.304 66.0%, k = 0.486
BF
   Improved delineation 6/39 (15.4%) 30/49 (61.2%) 3/12 (25.0%) 39/100 (39.0%)
   Percentage of agreement, k 76.9%, k = 0.558 81.6%, k = 0.570 25.0%, k = NA 79.0%, k = 0.593
FICE: Flexible Spectral Imaging Color Enhancement; BF: Blue Filter; NA: Not available.
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(Figure 2C).
DISCUSSION
Currently available data on the use of  virtual chromoen-
doscopy on SBCE are scarce, with conflicting results re-
ported in the literature regarding its accuracy and clinical 
value[7,11,22-24]. Moreover, there is ongoing discussion on 
what should be the optimal settings to improve the detec-
tion and/or delineation of  different types of  lesions[7,19]. 
Some important questions have been addressed[11], such 
as whether virtual chromoendoscopy may improve the 
detection rate of  clinically relevant lesions, and whether 
it may contribute to a better characterization of  lesions 
detected with conventional SBCE-WL. We should un-
derline that a significant number of  non-pathological or 
clinically irrelevant lesions may be detected when FICE is 
used, such as small red spots or prominent folds that may 
be erroneously interpreted as angioectasias when FICE is 
used[22]. Our study did not address this issue, since we did 
not perform a comparative evaluation of  the full video 
using white light vs virtual chromoendoscopy; indeed, 
all images of  the lesions selected to enter the study had 
been previously identified with SBCE-WL, as we aimed 
to evaluate whether virtual chromoendoscopy could im-
prove the delineation of  the most common lesions in the 
small bowel detected by the capsule. 
We observed that, overall, FICE 1 and FICE 2 im-
proved the delineation of  small bowel lesions in up to 
77% and 74% of  the cases, respectively, with almost per-
fect interobserver agreement for FICE 1 [k = 0.833 (P < 
0.001), 95%CI: 0.741-0.925] and substantial interobserver 
agreement for FICE 2 [k = 0.764 (P < 0.001), 95%CI: 
0.654-0.874]. Conversely, the interobserver agreement 
was moderate with FICE 3 [k = 0.486 (P < 0.001), 
95%CI: 0.345-0.627)] and BF [k = 0.593 (P < 0.001), 
95%CI: 0.438-0.748], and these settings only improved 
the delineation of  lesions in 41% and 39%, respectively. 
FICE 1 and FICE 2 were particularly useful improving 
the delineation of  angioectasias (97.4% with both set-
tings) and, to a lesser degree, ulcers/erosions (63.3% and 
57.1%, respectively) and villous edema/atrophy (66.7% 
with both settings). Overall, FICE 1 and FICE 2 were su-
perior to FICE 3 and BF for all types of  lesions, which is 
in line with other published data[6,7,25] (Table 2). Interest-
ingly, in the case of  ulcers/erosions, the BF yielded good 
results, comparable to FICE 1 and FICE 2, improving 
the delineation of  61.2% of  lesions, although with a 
lower interobserver agreement [k = 0.570 (P < 0.001), 
95%CI: 0.333-0.807].
The outcomes per type of  lesion may be summarized 
as follows: the delineation of  angioectasias was im-
proved with either FICE 1 or FICE 2 in almost all cases 
(97.4%); the delineation of  ulcers/erosions was improved 
in 57%-63% of  the cases with either FICE 1 (63.3%), 
FICE 2 (57.1%) or BF (61.2%); the delineation of  vil-
lous edema/atrophy was improved with either FICE 1 or 
FICE 2 in approximately two thirds (66.7%) of  the cases. 
As in other published studies[7,19,23], we found FICE 3 to 
respectively. The BF improved the delineation of  15.4% 
of  angioectasias, 61.2% of  ulcers/erosions and 25% of  
villous edema/atrophy, with a percentage of  agreement 
of  76.9% [k = 0.558 (P < 0.001), 95%CI: 0.264-0.852], 
81.6% [k = 0.570 (P < 0.001), 95%CI: 0.333-0.807] and 
25.0% (k = NA), respectively. The detailed outcomes in 
terms of  quality of  delineation per type of  lesion with 
each setting of  virtual chromoendoscopy are summarized 
in graphical representation for angioectasias (Figure 2A), 
ulcers/erosions (Figure 2B) and villous edema/atrophy 
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Figure 2  Delineation. A: Of angioectasias with all different settings of virtual 
chromoendoscopy: comparison with conventional white light; B: Of ulcers or 
erosions with all different settings of virtual chromoendoscopy: comparison with 
conventional white light; C: Of villous edema or atrophy with all different set-
tings of virtual chromoendoscopy: comparison with conventional white ligh.
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be ineffective for the vast majority of  small bowel mu-
cosal lesions. The results of  our study suggest that FICE 
1 (wavelengths red 595 nm, green 540 nm, blue 535 nm) 
seems to achieve the optimal appearance of  vascular and 
mucosal contrast for small bowel lesions, with the highest 
interobserver agreement among all settings of  FICE, and 
thus it should generally be the setting of  choice when 
using virtual chromoendoscopy. Imagawa et al[7] had re-
ported that both FICE 1 and FICE 2 could improve the 
delineation of  ulcers and erosions, however the detection 
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Table 2  Summary of publications on small bowel capsule endoscopy-virtual chromoendoscopy
Ref. Center Study type No. of patients Outcome Results
Imagawa et al[7] Single center Retrospective 122 patients Delineation 145 lesions
FICE 1: improved delineation in 87.0% (20/23) of angioectasias, 53.3% (26/47) 
of ulcers/erosions and 25.3% (19/75) of tumors
FICE 2: improved delineation in 87.0% (20/23) of angioectasias, 25.5% (12/47) 
of ulcers/erosions and 20.0% (15/75) of tumors
FICE 3: no improvement
Imagawa et al[6] Single center Prospective 50 patients Detection 
rate
FICE 1: increased detection rate of angioectasias (48 vs 17, P = 0.0003) 
FICE 2: increased detection rate of angioectasias (45 vs 17, P < 0.0001)
FICE 3: increased detection rate of angioectasias (24 vs 17, P = ns)
Detection of ulcers, erosions and tumors did not differ significantly between 
conventional SBCE-WL and SBCE-FICE
Gupta et al[22] Single center Retrospective 60 patients Detection 
rate
157 lesions detected with SBCE-FICE vs 114 with SBCE-WL (P = 0.15)
5/55 angioectasias were better characterized with SBCE-FICE 
More P0 diagnosed with SBCE-FICE (39 vs 8, P < 0.001)
Intra-class k correlations with SBCE-FICE: 0.88 (P2 lesions); 0.61 (P1 lesions)
Intra-class k correlations with SBCE-WL: 0.92 (P2 lesions); 0.79 (P1 lesions)
For P2 lesions, the sensitivity was 94% vs 97% and specificity was 95% vs 96% 
for SBCE-FICE and SBCE-WL, respectively
Krystallis et al[19] Single center Retrospective 200 patients Delineation 167 lesions including angioectasias (n = 18), erosions/ulcers (n = 60), villi 
oedema (n = 17), cobblestone (n = 11), blood lumen (n = 15), lesions of 
unknown clinical significance (n = 46) 
FICE 1: improved delineation in 34%; k = 0.646
FICE 2: improved delineation in 8.6%; k = 0.617
FICE 3: improved delineation in 7.7%; k = 0.669
Blue mode: improved delineation in 83%; k = 0.786
Duque et al[8] Single center Prospective 20 patients Detection 
rate
150 lesions
SBCE-FICE: increased detection rate (95 vs 75), k = 0.650
SBCE-FICE did not miss any lesion identified by CE-WL and allowed the 
identification of a higher number of angioectasias (35 vs 32, P = 0.25) and 
erosions (41 vs 24, P < 0.001) 
Nakamura et 
al[25]
Single center Prospective 50 patients Detection rate 
(QuickView)
SBCE-WL: sensitivity 80%, specificity 100%
SBCE-FICE: sensitivity 91% specificity 86%
SBCE-FICE resulted in more false positive findings and lower specificity 
Sakai et al[26] Single center Prospective 12 patients Detection 
rate
142 lesions including angioectasias (n = 60) and ulcers/erosions (n = 82)
Angioectasias were detected with CE-WL (26/60), SBCE-FICE 1 (40/60), 
SBCE-FICE 2 (38/60), SBCE-FICE 3 (31/60)
Ulcers/erosions were detected with SBCE-WL (38/82), SBCE-FICE 1 (62/82), 
SBCE-FICE 2 (60/82), SBCE-FICE 3 (20/82)
SBCE-FICE 1and 2 significantly increased the detection rate of angioectasias (P 
= 0.0017 and P = 0.014, respectively) and ulcers/erosions (P = 0.0012 and P = 
0.0094, respectively)
In poor bowel visibility conditions, SBCE-FICE yielded a high rate of false-
positive findings
Cotter et al Single center Retrospective 49 patients Delineation 100 lesions including angioectasias (n = 39), ulcers/erosions (n = 49), villous 
edema/atrophy (n = 12)
FICE 1: image improvement in 77% (k = 0.833)
FICE 2: image improvement in 74% (k = 0.764)
FICE 3: image improvement in 66% (k = 0.486)
BF: image improvement in 79% (k = 0.593)
FICE 1 improved the delineation of 97.4% of angioectasias, 63.3% of ulcers/
erosions and 66.7% of villous edema/atrophy
FICE 2 improved the delineation of 97.4% of angioectasias, 57.1% of ulcers/
erosions and 66.7% of villous edema/atrophy
FICE 3 improved the delineation of 46.2% of angioectasias, 24.5% of ulcers/
erosions and none of the cases of villous edema/atrophy
BF improved the delineation of 15.4% of angioectasias, 61.2% of ulcers/
erosions and 25.0% of villous edema/atrophy
FICE: Flexible Spectral Imaging Color Enhancement; BF: Blue Filter; SBCE-WL: White light small bowel capsule endoscopy.
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rate of  such lesions was similar between white light and 
virtual chromoendoscopy[6]. Similarly to our study, Krys-
tallis et al[19] reported a better delineation of  ulcers using 
the BF. Duque et al[8] reported an improvement in the 
diagnosis of  erosions using FICE 2, due to the enhance-
ment of  its inflammatory halo. Regarding villous edema/
atrophy, in our study it was better visualized with FICE 1 
and FICE 2, while other authors[19] have found edema to 
be better visualized with the BF mode. 
In summary, our results suggest that virtual chro-
moendoscopy, and particularly FICE 1, may be used in 
those cases where the characterization or interpretation 
of  small bowel lesions is not straightforward with con-
ventional SBCE-WL. On the other hand, in our study 
virtual chromoendoscopy did not lead to reclassification 
of  any of  the lesions detected with conventional SBCE-
WL, and we did not evaluate whether it could contribute 
to increase the diagnostic yield of  SBCE by identify-
ing new lesions previously undetected with SBCE-WL, 
as we evaluated pre-selected lesions, which had already 
been previously diagnosed. Moreover, in the absence 
of  a gold standard, it is not possible to accurately assess 
the false positives rate of  these new techniques. Thus, at 
this point, although virtual chromoendoscopy has been 
shown to improve the delineation of  small bowel lesions 
previously diagnosed by conventional SBCE-WL, the im-
pact of  this technology on the detection rate, accuracy of  
diagnosis and improved clinical outcome warrants further 
investigation. Our data support the current use of  vir-
tual chromoendoscopy as a complement to conventional 
white light SBCE for the evaluation of  difficult to inter-
pret endoscopic images.
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Background
One of the recent technical advances of small bowel capsule endoscopy (SBCE) 
is the possibility to enhance endoscopic imaging with computed virtual chro-
moendoscopy, using the Flexible Spectral Imaging Color Enhancement (FICE) 
or the Blue Filter (BF) modes. However, it is currently controversial whether 
virtual chromoendoscopy may increase the diagnostic yield and diagnostic ac-
curacy of SBCE, and what are the optimal wavelength filters to be used. 
Research frontiers
The authors aimed to evaluate whether different settings of FICE or the Blue 
Filter could improve the delineation of the most frequent small bowel mucosal 
lesions detected by conventional white light small bowel capsule endoscopy 
(SBCE-WL), namely the three main types of small bowel mucosal lesions: vas-
cular (angioectasias), mucosal breaks (ulcers and erosions) and villous pattern 
(edema and atrophy).
Innovations and breakthroughs
Virtual chromoendoscopy improved the delineation of three main types of small 
bowel mucosal lesions: vascular (angioectasias), mucosal breaks (ulcers and 
erosions) and villous pattern (edema and atrophy). FICE 1 (wavelengths red 
595 nm, green 540 nm, blue 535 nm) seems to achieve the optimal appearance 
of vascular and mucosal contrast for small bowel lesions, with the highest in-
terobserver agreement among all settings of FICE, and thus it should generally 
be the setting of choice when using virtual chromoendoscopy.
Applications
The results suggest that virtual chromoendoscopy, and particularly FICE 1, may 
be used in those cases where the characterization or interpretation of small 
bowel lesions is not straightforward with conventional SBCE-WL. Authors’ sup-
port the use of virtual chromoendoscopy as a complement to conventional white 
light SBCE for the evaluation of difficult to interpret endoscopic images. 
Terminology
FICE (Fujinon Corporation®, Saitama, Japan) is a computed virtual chromo-
endoscopy modality that uses a spectral estimation technology, narrowing 
the bandwidth of white light that permits an automatic reconstruction of pre-
acquired conventional endoscopic images into virtual images with different 
wavelengths of red, green and blue, in order to enhance vascular contrast and 
the resolution of surface patterns. BF is a different setting of virtual chromo-
endoscopy consisting of colour enhancement within a short wavelength range 
(490-430 nm).
Peer review
In a retrospective study, the authors have evaluated virtual chromoendoscopy 
SBCE in the delineation of small bowel lesions previously detected by white 
light SBCE. The virtual chromoendoscopy included 3 types of FICE and a blue 
filter. This is an interesting report.
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